cabozantinib,atezolizumab
exelixis,roche
['urothelial']
great presentation by of the results of cabo-atezo in urothelial tumors. encouraging data. #asco22 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid